Floatz logo

WARFARIN

Heart Valve Disorder

Hospital Geral Roberto SantosSmall moleculePhase 2/3Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Heart Valve Disorder cohort.

Same molecule, other indications

WARFARIN is also rated in:

venous thromboembolismDormant
A
Indicative · Phase 4
81 / 100
View asset →
atrial fibrillationActive
BBB
Indicative · Phase 4
77 / 100
View asset →
hemorrhagic diseaseActive
BBB
Indicative · Phase 4
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →